Stay updated on IMMU-132 Clinical Trial in Epithelial Cancer
Sign up to get notified when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.
Latest updates to the IMMU-132 Clinical Trial in Epithelial Cancer page
- CheckyesterdayChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible edits to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedDifference0.9%
- Check51 days agoChange DetectedAdditions clarify publication provenance: voluntariness of submissions, PubMed auto-fill, and a Revision: v3.3.2 tag. Deletions remove older phrasing that publications are automatically created by ClinicalTrials.gov using the NCT number and may be about the study results.SummaryDifference0.1%
- Check58 days agoChange DetectedRemoval of the funding-status notice about potential delays due to government funding; this did not affect the study data or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check72 days agoChange DetectedMinor layout/formatting updates to the Study Details page; no changes to core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check101 days agoChange DetectedUpdate includes new version tag v3.2.0 and a government-operating-status notice; removes two specific disease terms from prior content. Overall, marks a shift in page status and less emphasis on prior disease-specific items.SummaryDifference2%
Stay in the know with updates to IMMU-132 Clinical Trial in Epithelial Cancer
Enter your email address, and we'll notify you when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.